Stocks
Denali Therapeutics (DNLI) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -205.2 | 62.7 | -287.2 | -330.4 | -180.0 | -498.3 | ||
| Changes by years, y/y, % | +342% | -131% | -558% | +15% | -46% | +31.2% | |||
Denali Therapeutics. EBITDA US GAAP, bln rub
Denali Therapeutics. EBITDA US GAAP, changes, %
Denali Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Denali Therapeutics (DNLI) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -111.6 | -130.4 | -130.1 | -114.7 | -123.2 | -498.3 | |
| Changes by years, y/y, % | +6% | +29% | +8% | -167% | +10% | |||
| Changes by quarters, q/q, % | -165% | +17% | 0% | -12% | +7% | |||
